Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

The influence of tacrolimus vs. cyclosporine-a on early results of orthotopic heart transplantation (OHT)

A Barańska-Kosakowska, M Zakliczyński, M Zembala

Ann Transplant 2009; 14(1): 67-67 :: ID: 880445


Background: There are few studies suggesting prevalence of tacrolimus in preventing acute rejection of the graft in comparison to cyclosporine-A in patients after OHT. Aim. The aim of the study was to assess early results of OHT after introduction of tacrolimus as part of the primary immunosuppressive protocol.
Material/Methods: We analyzed the results of 328 consecutive OHT procedures performed in the Silesian Centre for Heart Disease between 18.06.2000 and 30.06.2008. In the primary immunosuppression tacrolimus was used in 72 pts (group A; 59M/13F, 48±10 y.o.), cyclosporine-A in 214 pts. (group B; 188M/26F, 45±16 y.o.). 1.year survival, acute rejection (AR), glomerular filtration rate (GFR) and infection episodes were assessed.
Results: 1-year survival was 77% and was the same in both groups. Primary
graft failure was the cause of all 42 deaths. AR episodes occurred in 64
vs.78% of pts. in group A compared to group B (p=0.02). Average number of AR>3A was 1.1±1.0 vs. 2.0±1.8 (p=0.01) in the group A vs.B respectively. GFR in the first month after OHT was 89.1±46.0 vs.78.4±32.4 in group A compared to group B (p=0.02). The rate of bacterial and viral infection was similar in both groups (31%).
Conclusions: Tacrolimus used in primary immunosuppressive protocol is related to the same survival and infectious complications, but to lesser degree of acute rejection and renal impairment in comparison to cyclosporine-A.

Keywords: Heart Transplantation, Immunosuppression

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358